Clinical Trials Browser

Completed × liposomal doxorubicin × Genitourinary × Clear all

NCT00456989 2019-10-30

Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer

Phase 1/2 Completed

39 enrolled 4 charts

Prostatic Neoplasms

NCT00307294 2017-11-24

Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)

Phase 2 Completed

40 enrolled 8 charts

Prostatic Neoplasms

NCT00630409 2017-03-10

Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Phase 2 Completed

5 enrolled 2 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02262455 2017-02-13

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma